Regulatory Roles of the Caspase-11 Non-Canonical Inflammasome in Inflammatory Diseases
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Inflammation is an immune response mediated by innate immune cells of tissues, against invading microbes and cellular stress. The hallmark of inflammatory responses is the activation of inflammasomes — multiprotein oligomers comprising intracellular pattern recognition receptors and inflammatory effectors — such as ASC and pro-cysteine-aspartic protease (pro-caspase)-1. Inflammasomes can be classified as canonical or non-canonical, and their activation in response to various ligands commonly induces caspase-1 activation and gasdermin D (GSDMD) processing, leading to caspase-1-mediated maturation and secretion of the pro-inflammatory cytokines IL-1β and IL-18, and GSDMD-mediated pyroptosis through pore generation in cell membranes. Although inflammation protects the host from harmful stimuli, chronic inflammation is a critical risk factor for inflammatory diseases, and several studies have investigated the role of canonical inflammasomes in inflammatory responses and diseases, with emerging studies focusing on the role of non-canonical inflammasomes. This review discusses recent studies on the regulatory roles of the caspase-11 non-canonical inflammasome in the pathogenesis of inflammatory diseases. Additionally, it provides an insight into the development of novel therapeutics based on targeting caspase-11 non-canonical inflammasome and its downstream effectors to prevent and treat human inflammatory conditions.
Abstract
Inflammation is an immune response mediated by innate immune cells of tissues, against invading microbes and cellular stress. The hallmark of inflammatory responses is the activation of inflammasomes — multiprotein oligomers comprising intracellular pattern recognition receptors and inflammatory effectors — such as ASC and pro-cysteine-aspartic protease (pro-caspase)-1. Inflammasomes can be classified as canonical or non-canonical, and their activation in response to various ligands commonly induces caspase-1 activation and gasdermin D (GSDMD) processing, leading to caspase-1-mediated maturation and secretion of the pro-inflammatory cytokines IL-1β and IL-18, and GSDMD-mediated pyroptosis through pore generation in cell membranes. Although inflammation protects the host from harmful stimuli, chronic inflammation is a critical risk factor for inflammatory diseases, and several studies have investigated the role of canonical inflammasomes in inflammatory responses and diseases, with emerging studies focusing on the role of non-canonical inflammasomes. This review discusses recent studies on the regulatory roles of the caspase-11 non-canonical inflammasome in the pathogenesis of inflammatory diseases. Additionally, it provides an insight into the development of novel therapeutics based on targeting caspase-11 non-canonical inflammasome and its downstream effectors to prevent and treat human inflammatory conditions.
참고문헌 (76)
- Janeway CA Jr, "Innate immune recognition", Annu Rev Immunol, 20, pp.197~216 (2002)
- 이영수, "Folate Receptor-Targeted Diagnostics and Therapeutics for Inflammatory Diseases", Immune Network, 16(6), pp.337~343 (2016), 대한면역학회[DOI]
- Takeuchi O, "Pattern recognition receptors and inflammation", Cell, 140, pp.805~820 (2010)
- Broz P, "Inflammasomes: mechanism of assembly, regulation and signalling", Nat Rev Immunol, 16, pp.407~420 (2016)
- Yi YS., "Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses", Immunology, 152, pp.207~217 (2017)
- Yi YS, "Functional roles of Syk in macrophage-mediated inflammatory responses", Mediators Inflamm, 2014, pp.270302~ (2014)
- Yang Y, "Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses", Mediators Inflamm, 2014, pp.352371~ (2014)
- Yu T, "The pivotal role of TBK1 in inflammatory responses mediated by macrophages", Mediators Inflamm, 2012, pp.979105~ (2012)
- Byeon SE, "The role of Src kinase in macrophage-mediated inflammatory responses", Mediators Inflamm, 2012, pp.512926~ (2012)
- Chen G, "NOD-like receptors: role in innate immunity and inflammatory disease", Annu Rev Pathol, 4, pp.365~398 (2009)
- 이영수, "Role of inflammasomes in inflammatory autoimmune rheumatic diseases", The Korean Journal of Physiology & Pharmacology, 22(1), pp.1~15 (2018), 대한약리학회[DOI]
- Lamkanfi M, "In retrospect: The inflammasome turns 15", Nature, 548, pp.534~535 (2017)
- Man SM, "Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases", Immunol Rev, 277, pp.61~75 (2017)
- Lamkanfi M, "Mechanisms and functions of inflammasomes", Cell, 157, pp.1013~1022 (2014)
- Sarvestani ST, "The role of the NLRP3 inflammasome in regulation of antiviral responses to influenza A virus infection", Antiviral Res, 148, pp.32~42 (2017)
- Tőzsér J, "Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1β Production", Mediators Inflamm, 2016, pp.5460302~ (2016)
- Alnemri ES., "Sensing cytoplasmic danger signals by the inflammasome", J Clin Immunol, 30, pp.512~519 (2010)
- Fernandes-Alnemri T, "The AIM2 inflammasome is critical for innate immunity to Francisella tularensis", Nat Immunol, 11, pp.385~393 (2010)
- Rathinam VA, "The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses", Nat Immunol, 11, pp.395~402 (2010)
- Mariathasan S, "Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf", Nature, 430, pp.213~218 (2004)
- Miao EA, "Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf", Nat Immunol, 7, pp.569~575 (2006)
- Zhao Y, "The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus", Nature, 477, pp.596~600 (2011)
- Kayagaki N, "Non-canonical inflammasome activation targets caspase-11", Nature, 479, pp.117~121 (2011)
- Wang S, "Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE", Cell, 92, pp.501~509 (1998)
- Ding J, "Snapshot: the noncanonical inflammasome", Cell, 168, pp.544.e1~544.e1 (2017)
- Vanaja SK, "Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation", Cell, 165, pp.1106~1119 (2016)
- Viganò E, "Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes", Nat Commun, 6, pp.8761~ (2015)
- Casson CN, "Human caspase-4 mediates noncanonical inflammasome activation against gram-negative bacterial pathogens", Proc Natl Acad Sci U S A, 112, pp.6688~6693 (2015)
- Yi YS., "Regulatory roles of flavonoids on inflammasome activation during inflammatory responses", Mol Nutr Food Res, 62, pp.e1800147~ (2018)
- Shi J, "Inflammatory caspases are innate immune receptors for intracellular LPS", Nature, 514, pp.187~192 (2014)
- Hagar JA, "Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock", Science, 341, pp.1250~1253 (2013)
- Kayagaki N, "Noncanonical inflammasome activation by intracellular LPS independent of TLR4", Science, 341, pp.1246~1249 (2013)
- He WT, "Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion", Cell Res, 25, pp.1285~1298 (2015)
- Shi J, "Pyroptosis: gasdermin-mediated programmed necrotic cell death", Trends Biochem Sci, 42, pp.245~254 (2017)
- Aglietti RA, "GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes", Proc Natl Acad Sci U S A, 113, pp.7858~7863 (2016)
- Ding J, "Pore-forming activity and structural autoinhibition of the gasdermin family", Nature, 535, pp.111~116 (2016)
- Liu X, "Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores", Nature, 535, pp.153~158 (2016)
- Lee BL, "Caspase-11 auto-proteolysis is crucial for noncanonical inflammasome activation", J Exp Med, 215, pp.2279~2288 (2018)
- Sborgi L, "GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death", EMBO J, 35, pp.1766~1778 (2016)
- Shi J, "Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death", Nature, 526, pp.660~665 (2015)
- Kayagaki N, "Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling", Nature, 526, pp.666~671 (2015)
- van de Veerdonk FL, "Inflammasome activation and IL-1β and IL-18 processing during infection", Trends Immunol, 32, pp.110~116 (2011)
- Evavold CL, "The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages", Immunity, 48, pp.35.e6~44.e6 (2018)
- Heilig R, "The gasdermin-D pore acts as a conduit for IL-1β secretion in mice", Eur J Immunol, 48, pp.584~592 (2018)
- Rühl S, "Caspase-11 activates a canonical NLRP3 inflammasome by promoting K+ efflux", Eur J Immunol, 45, pp.2927~2936 (2015)
- Zanoni I, "An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells", Science, 352, pp.1232~1236 (2016)
- Rathinam VA, "TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria", Cell, 150, pp.606~619 (2012)
- Broz P, "Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1", Nature, 490, pp.288~291 (2012)
- Aachoui Y, "Canonical inflammasomes drive IFN-γ to prime caspase-11 in defense against a cytosol-invasive bacterium", Cell Host Microbe, 18, pp.320~332 (2015)
- Wiersinga WJ, "Melioidosis", N Engl J Med, 367, pp.1035~1044 (2012)
- Schroeder N, "Salmonella-induced tubular networks", Trends Microbiol, 19, pp.268~277 (2011)
- Ge J, "Manipulation of host vesicular trafficking and innate immune defence by Legionella Dot", Icm effectors, 2011, pp.13, 1870~1880
- Aachoui Y, "Caspase-11 protects against bacteria that escape the vacuole", Science, 339, pp.975~978 (2013)
- Amor S, "Inflammation in neurodegenerative diseases--an update", Immunology, 142, pp.151~166 (2014)
- Hisahara S, "Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination", J Exp Med, 193, pp.111~122 (2001)
- Kang SJ, "Dissociation between neurodegeneration and caspase-11-mediated activation of caspase-1 and caspase-3 in a mouse model of amyotrophic lateral sclerosis", J Neurosci, 23, pp.5455~5460 (2003)
- Furuya T, "Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease", J Neurosci, 24, pp.1865~1872 (2004)
- Chu LH, "The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages", Nat Commun, 9, pp.996~ (2018)
- Baumgart DC, "Inflammatory bowel disease: cause and immunobiology", Lancet, 369, pp.1627~1640 (2007)
- Baumgart DC, "Inflammatory bowel disease: clinical aspects and established and evolving therapies", Lancet, 369, pp.1641~1657 (2007)
- Xavier RJ, "Unravelling the pathogenesis of inflammatory bowel disease", Nature, 448, pp.427~434 (2007)
- Demon D, "Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis", Mucosal Immunol, 7, pp.1480~1491 (2014)
- Williams TM, "Caspase-11 attenuates gastrointestinal inflammation and experimental colitis pathogenesis", Am J Physiol Gastrointest Liver Physiol, 308, pp.G139~G150 (2015)
- Chen Y, "Mesenchymal stromal cells directly promote inflammation by canonical NLRP3 and non-canonical caspase-11 inflammasomes", EBioMedicine, 32, pp.31~42 (2018)
- Smolen JS, "Rheumatoid arthritis", Nat Rev Dis Primers, 4, pp.18001~ (2018)
- Yi YS, "Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: comparison of hapten potencies", Mol Pharm, 6, pp.1228~1236 (2009)
- Szekanecz Z, "Macrophages and their products in rheumatoid arthritis", Curr Opin Rheumatol, 19, pp.289~295 (2007)
- Lacey CA, "Caspases-1 and caspase-11 mediate pyroptosis, inflammation, and control of Brucella joint infection", Infect Immun, 86 (2018)
- Ignatova GL, "New opportunities for inhaled therapy for inflammatory diseases of the respiratory system", Ter Arkh, 89, pp.110~112 (2017)
- Xie JL, "Recent advances in the study of Nrf2 and inflammatory respiratory diseases", Yao Xue Xue Bao, 50, pp.1080~1087 (2015)
- Zarogoulidis P, "Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases", Eur J Clin Pharmacol, 68, pp.479~503 (2012)
- Cheng KT, "Caspase-11-mediated endothelial pyroptosis underlies endotoxemia-induced lung injury", J Clin Invest, 127, pp.4124~4135 (2017)
- Eltom S, "Role of the inflammasome-caspase1", 11-IL-1, PLoS One, pp.2014, 9[DOI]
- as a therapeutic candidate for asthma and chronic obstructive pulmonary disease, "J Pharmacol Exp Ther", 2009, 758~765
- Hoenderdos K, "The neutrophil in chronic obstructive pulmonary disease", Am J Respir Cell Mol Biol, 48, pp.531~539 (2013)
- Kaur M, "Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1", CXCR2, 2013, pp.347, 173~180
